Pharmacodynamic interplay of the P2Y 1, P2Y 12, and TxA 2 pathways in platelets: The potential of triple antiplatelet therapy with P2Y 1 receptor antagonism
JH Oestreich, SP Ferraris, SR Steinhubl, WS Akers - Thrombosis research, 2013 - Elsevier
... Adenosine diphosphate (ADP), collagen (both from Chrono-log, Havertown, PA, USA), and
thrombin receptor activating peptide-6 amide (TRAP-6; Bachem Americas, Inc., Torrance, CA,
USA) were utilized as platelet agonists for all ex vivo platelet assays. ...
thrombin receptor activating peptide-6 amide (TRAP-6; Bachem Americas, Inc., Torrance, CA,
USA) were utilized as platelet agonists for all ex vivo platelet assays. ...
没有评论:
发表评论